Verisk Analytics Inc (VRSK)

Equifax Inc. (NYSE:EFX) is set to go ex-dividend in the next three days, with a payment of US$0.56 per share, contributing to a trailing yield of 1.2%. The company's dividend appears sustainable, as it pays out a comfortable 37% of profits and 23% of free cash flow. With earnings per share growing at 6.6% over the last five years and management reinvesting in the business, Equifax shows potential for continued dividend growth.

Verisk Analytics (VRSK) is seeing fresh institutional investor interest, with multiple asset managers initiating or increasing stakes, even as analysts maintain a "Hold" rating and a modest target price of $236.27. These significant institutional inflows suggest long-term confidence in Verisk's stable, recurring revenue model in insurance analytics, despite the limited upside implied by analyst consensus. The company's business model is anchored in providing data-driven analytics and decision-support tools to the global insurance industry and related markets.

Verisk Analytics Inc. (VRSK) stock increased by 1.09% to $189.55, outperforming the broader market which saw mixed results with the Dow Jones Industrial Average rising and the S&P 500 Index falling. The company's stock is currently 31.02% below its 52-week high of $274.78.

Verisk Analytics (VRSK) shares have declined by 6.3% since its last earnings report, despite the company exceeding Q1 2026 earnings and revenue estimates. The company reported strong performance in its Insurance business, with both underwriting and claims revenues increasing, driven by fraud analytics strength and price increases. Verisk reaffirmed its full-year 2026 guidance, expecting continued revenue and adjusted EBITDA growth.

Verisk Analytics (VRSK) reported Q2 2026 adjusted EPS and revenue that exceeded analyst forecasts, driven by strong subscription revenue and other business lines. Despite a 9.58% rise in share price over the last 90 days, the year-to-date return is down 15.17%, and the one-year total shareholder return has declined 30.20%. While one narrative suggests the stock is 144% overvalued with a fair value of $76.85, Simply Wall St's DCF model estimates a fair value of $231.91, indicating a 19.2% undervaluation compared to its current price of $187.50.